麦德佩斯临床研究 MEDP
$653.11 +$18.13 (+2.86%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $653.11 0.00%
开盘$635.01
昨收$634.98
当日区间$635.00 – $657.77
成交量231.6K
市值$18.27B
市盈率（TTM）36.3
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$716.00M+8.5% YoY
营业利润$165.54M+16.7% YoY
净利润$137.46M+23.7% YoY
摊薄每股收益$4.84+25.4% YoY
自由现金流$196.44M-16.6% YoY
经营现金流$216.60M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率29.1%
营业利润率21.4%
净利率18.2%
净资产收益率117.9%
资产收益率25.5%
投入资本回报率90.6%
流动比率0.83
负债/资产比率74.6%
现金及投资$705.32M
总负债$146.04M
净现金（净负债）$559.27M
自由现金流/营收23.5%
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $716.00M | $707.33M | $706.60M | $2.53B | $708.45M |
| 营业总收入 | $716.00M | $707.33M | $706.60M | $2.53B | $708.45M |
| 营业成本 | $492.12M | $505.69M | $510.28M | $1.77B | $503.13M |
| 毛利润 | $223.89M | $201.64M | $196.33M | $760.62M | $205.32M |
| 营业费用 | $58.35M | $54.81M | $54.82M | $225.68M | $52.05M |
| 销售及管理费用 | $51.77M | $48.10M | $47.92M | $197.56M | $44.92M |
| 折旧、摊销与折耗 | $6.58M | $6.71M | $6.91M | $28.12M | $7.13M |
| -折旧与摊销 | $6.58M | $6.71M | $6.91M | $28.12M | $7.13M |
| 营业利润 | $165.54M | $146.82M | $141.50M | $534.94M | $153.27M |
| 非经营性利息净收入（支出） | $5.35M | $4.99M | $5.12M | $12.78M | $3.72M |
| 其他财务成本合计 | -$5.35M | -$4.99M | -$5.12M | -$12.78M | -$3.72M |
| 其他收入（支出） | $17,000.00 | -$147,000.00 | $971,000.00 | -$5.34M | -$158,000.00 |
| 其他非经营性收入（支出） | $17,000.00 | -$147,000.00 | $971,000.00 | $2.39M | $7.57M |
| 税前利润 | $170.91M | $151.66M | $147.59M | $542.38M | $156.83M |
| 税费 | $33.45M | $30.30M | $23.72M | $91.25M | $21.70M |
| 净利润 | $137.46M | $121.36M | $123.87M | $451.12M | $135.13M |
| 持续经营利润 | $137.46M | $121.36M | $123.87M | $451.12M | $135.13M |
| 归属母公司净利润 | $137.46M | $121.36M | $123.87M | $451.12M | $135.13M |
| 其他优先股股息 | $0.00 | – | – | $0.00 | $0.00 |
| 归属普通股股东净利润 | $137.46M | $121.36M | $123.87M | $451.12M | $135.13M |
| 基本每股收益 | $4.92 | $4.31 | $4.35 | $15.64 | $4.78 |
| 摊薄每股收益 | $4.84 | $4.25 | $4.28 | $15.28 | $4.67 |
| 证券出售收益 | – | – | – | -$7.73M | – |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $2.30B | $2.06B | $2.13B | $1.98B | $1.98B |
| 流动资产合计 | $1.25B | $1.05B | $1.14B | $989.62M | $989.62M |
| 现金及现金等价物与短期投资 | $705.32M | $502.69M | $652.68M | $497.05M | $497.05M |
| -现金及现金等价物 | $705.32M | $502.69M | $652.68M | $497.05M | $497.05M |
| 应收款 | $447.64M | $441.80M | $394.58M | $402.08M | $402.08M |
| -应收账款 | $419.84M | $420.56M | $370.41M | $376.76M | $376.76M |
| -其他应收款 | $27.83M | $21.27M | $24.20M | $25.35M | $25.35M |
| -应收款调整准备 | -$28,000.00 | -$28,000.00 | -$28,000.00 | -$29,000.00 | -$29,000.00 |
| 其他流动资产 | $92.04M | $105.80M | $91.79M | $90.50M | $90.50M |
| 非流动资产合计 | $1.06B | $1.01B | $990.56M | $985.85M | $985.85M |
| 固定资产净值 | $327.55M | $282.96M | $263.36M | $248.87M | $248.87M |
| -固定资产原值 | $327.55M | $282.96M | $263.36M | $372.14M | $372.14M |
| 商誉及其他无形资产 | $695.35M | $695.51M | $695.66M | $695.82M | $695.82M |
| -商誉 | $662.40M | $662.40M | $662.40M | $662.40M | $662.40M |
| -其他无形资产 | $32.96M | $33.11M | $33.27M | $33.42M | $33.42M |
| 一年以上递延资产 | $3.27M | $3.23M | $3.22M | $19.22M | $19.22M |
| 其他非流动资产 | $31.42M | $25.20M | $28.32M | $21.94M | $21.94M |
| 负债合计 | $1.72B | $1.62B | $1.53B | $1.52B | $1.52B |
| 流动负债合计 | $1.50B | $1.44B | $1.35B | $1.34B | $1.34B |
| 应付款 | $43.68M | $37.53M | $34.43M | $28.14M | $28.14M |
| -应付账款 | $43.68M | $37.53M | $34.43M | $28.14M | $28.14M |
| 一年内应计费用 | $344.86M | $371.65M | $344.46M | $328.24M | $328.24M |
| 一年内递延负债 | $961.86M | $904.72M | $856.34M | $854.39M | $854.39M |
| 其他流动负债 | $47.23M | $42.10M | $48.18M | $52.83M | $52.83M |
| 非流动负债合计 | $221.56M | $187.89M | $186.29M | $172.65M | $172.65M |
| 长期债务及融资租赁负债 | $146.04M | $120.10M | $122.26M | $113.64M | $113.64M |
| -长期融资租赁负债 | $146.04M | $120.10M | $122.26M | $113.64M | $113.64M |
| 一年以上递延负债 | $13.66M | $8.21M | $3.93M | $1.36M | $1.36M |
| 其他非流动负债 | $61.86M | $59.58M | $60.10M | $57.66M | $57.66M |
| 股东权益合计 | $584.94M | $433.86M | $598.31M | $459.07M | $459.07M |
| 股东权益 | $584.94M | $433.86M | $598.31M | $459.07M | $459.07M |
| 股本 | $280,000.00 | $279,000.00 | $286,000.00 | $284,000.00 | $284,000.00 |
| -普通股 | $280,000.00 | $279,000.00 | $286,000.00 | $284,000.00 | $284,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $978.28M | $964.18M | $953.42M | $935.83M | $935.83M |
| 留存收益 | -$373.57M | -$511.37M | -$336.11M | -$459.98M | -$459.98M |
| 减：库存股 | $12.15M | $12.15M | $12.16M | $12.16M | $12.16M |
| 不影响留存收益的损益 | -$7.90M | -$7.08M | -$7.12M | -$4.91M | -$4.91M |
| -累计折旧 | – | – | – | -$123.27M | -$123.27M |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $216.60M | $162.01M | $151.79M | $713.22M | $192.65M |
| 持续经营经营活动现金流净额 | $216.60M | $162.01M | $151.79M | $713.22M | $192.65M |
| 持续经营净利润 | $137.46M | $121.36M | $123.87M | $451.12M | $135.13M |
| 折旧、折耗与摊销 | $6.58M | $6.71M | $6.91M | $28.12M | $7.13M |
| 递延税款 | $5.40M | $4.28M | $18.54M | $80.77M | $17.41M |
| 其他非现金项目 | $6.58M | $5.91M | $6.25M | $22.14M | $5.24M |
| 营运资金变动 | $52.98M | $19.40M | -$8.70M | $96.28M | $22.12M |
| -应收款变动 | -$5.79M | -$47.18M | $7.82M | -$106.22M | -$29.10M |
| -预付资产变动 | $13.37M | -$14.15M | -$1.80M | -$27.10M | -$11.49M |
| -应付账款及应计费用变动 | -$6.10M | $44.89M | -$1.22M | $99.71M | $40.90M |
| -其他流动负债变动 | -$5.45M | -$7.06M | -$5.29M | -$25.16M | -$7.03M |
| -其他营运资金变动 | $56.95M | $42.91M | -$8.22M | $155.04M | $28.84M |
| 投资活动现金流净额 | -$20.14M | -$23.89M | -$6.75M | -$31.14M | -$4.47M |
| 持续经营投资活动现金流净额 | -$20.14M | -$23.89M | -$6.75M | -$31.14M | -$4.47M |
| 其他投资变动净额 | $23,000.00 | $26,000.00 | $66,000.00 | $216,000.00 | $63,000.00 |
| 筹资活动现金流 | $6.50M | -$288.34M | $12.67M | -$860.39M | $22.73M |
| 持续经营筹资活动现金流净额 | $6.50M | -$288.34M | $12.67M | -$860.39M | $22.73M |
| 普通股发行净额 | $0.00 | -$294.76M | $0.00 | -$917.39M | $0.00 |
| 股票期权行使所得 | $6.50M | $6.42M | $12.67M | $57.00M | $22.73M |
| 期末现金余额 | $705.32M | $502.69M | $652.68M | $497.05M | $497.05M |
| 现金净变动 | $202.96M | -$150.21M | $157.71M | -$178.31M | $210.91M |
| 期初现金余额 | $502.69M | $652.68M | $497.05M | $669.44M | $285.35M |
| 汇率变动影响 | -$328,000.00 | $221,000.00 | -$2.08M | $5.92M | $790,000.00 |
| 自由现金流 | $196.44M | $138.10M | $144.97M | $681.87M | $188.12M |
| 资本支出 | – | -$23.91M | -$6.81M | – | – |
| 固定资产购置及出售净额 | – | – | – | -$31.36M | -$4.54M |
| 债务发行及偿还净额 | – | – | – | $0.00 | – |
暂无评论——快来第一个聊聊 MEDP。